Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

SELL
$4.02 - $10.43 $1.61 Million - $4.18 Million
-400,722 Closed
0 $0
Q1 2022

May 04, 2022

SELL
$8.43 - $20.9 $30,634 - $75,950
-3,634 Reduced 0.9%
400,722 $3.65 Million
Q4 2021

Feb 02, 2022

BUY
$19.26 - $30.08 $6.9 Million - $10.8 Million
358,013 Added 772.53%
404,356 $8.27 Million
Q3 2021

Nov 10, 2021

BUY
$24.86 - $35.02 $342,023 - $481,805
13,758 Added 42.22%
46,343 $1.18 Million
Q2 2021

Aug 12, 2021

BUY
$22.3 - $36.02 $33,606 - $54,282
1,507 Added 4.85%
32,585 $1.14 Million
Q1 2021

May 11, 2021

BUY
$26.38 - $51.15 $819,837 - $1.59 Million
31,078 New
31,078 $1.04 Million

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $472M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Banque Pictet & Cie Sa Portfolio

Follow Banque Pictet & Cie Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Pictet & Cie Sa, based on Form 13F filings with the SEC.

News

Stay updated on Banque Pictet & Cie Sa with notifications on news.